88.59
Healthequity Inc stock is traded at $88.59, with a volume of 1.02M.
It is down -1.22% in the last 24 hours and down -7.27% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$89.68
Open:
$90.11
24h Volume:
1.02M
Relative Volume:
1.00
Market Cap:
$7.63B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
81.28
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
-8.23%
1M Performance:
-7.27%
6M Performance:
+6.77%
1Y Performance:
+13.32%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
HQY
Healthequity Inc
|
88.59 | 7.73B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
VEEV
Veeva Systems Inc
|
296.28 | 49.30B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
91.66 | 15.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
73.26 | 13.48B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
38.64 | 7.29B | 906.14M | -52.62M | 89.62M | -0.3621 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-22-25 | Resumed | RBC Capital Mkts | Outperform |
Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
Dec-04-24 | Initiated | Mizuho | Outperform |
Nov-15-24 | Initiated | Goldman | Neutral |
Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
Apr-02-24 | Reiterated | JP Morgan | Overweight |
Jan-03-24 | Initiated | Barclays | Overweight |
Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Jul-12-22 | Initiated | Goldman | Sell |
Apr-11-22 | Initiated | Wells Fargo | Overweight |
Apr-07-22 | Initiated | Guggenheim | Buy |
Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-02-21 | Initiated | Jefferies | Buy |
Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Jul-02-21 | Initiated | Stephens | Overweight |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Jan-07-21 | Initiated | BTIG Research | Neutral |
Dec-08-20 | Reiterated | Barrington Research | Outperform |
Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
Apr-14-20 | Initiated | Guggenheim | Buy |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Mar-17-20 | Reiterated | Barrington Research | Outperform |
Oct-07-19 | Initiated | Goldman | Neutral |
Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
May-23-18 | Initiated | BofA/Merrill | Buy |
Apr-24-18 | Resumed | JP Morgan | Overweight |
Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Strategies to average down on HealthEquity Inc.Weekly Trade Report & Verified Stock Trade Ideas - newser.com
Can HealthEquity Inc. (2HE) stock sustain free cash flowCEO Change & Free Community Consensus Stock Picks - newser.com
Can HealthEquity Inc. (2HE) stock ride next bull market cycleWeekly Trade Recap & Scalable Portfolio Growth Methods - newser.com
Evaluating HealthEquity Inc. with trendline analysisFed Meeting & Capital Efficient Trading Techniques - newser.com
How sustainable is HealthEquity Inc. stock dividend payoutJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
How analysts revise price targets for HealthEquity Inc. (2HE) stock2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
Can HealthEquity Inc. stock resist market sell offsSwing Trade & High Conviction Investment Ideas - newser.com
Sentiment analysis tools applied to HealthEquity Inc.Gap Up & Breakout Confirmation Trade Signals - newser.com
How to integrate HealthEquity Inc. into portfolio analysis toolsChart Signals & Verified Short-Term Plans - newser.com
Key resistance and support levels for HealthEquity Inc.July 2025 Reactions & Safe Capital Growth Tips - newser.com
Is HealthEquity Inc. stock a contrarian buyJuly 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Is HealthEquity Inc. (2HE) stock attractive for growth funds2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
HealthEquity (HQY) Down 5.1% Since Last Earnings Report: Can It Rebound? - sharewise.com
Is HealthEquity Inc a good long term investmentSmall Cap Stock Opportunities & Collaborate and Win Together - earlytimes.in
HealthEquity (NASDAQ:HQY) Stock Price Down 4.5%Should You Sell? - MarketBeat
Avior Wealth Management LLC Takes $400,000 Position in HealthEquity, Inc. $HQY - MarketBeat
How to build a custom watchlist for HealthEquity Inc.2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
How Do Investors Really Feel About HealthEquity Inc? - Benzinga
What analysts say about HealthEquity Inc stockHigh Beta Stocks & Free Realize Exceptional Returns - earlytimes.in
HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings And 26.76% Upside Potential - DirectorsTalk Interviews
Overbrook Management Corp Lowers Stock Position in HealthEquity, Inc. $HQY - MarketBeat
Is HealthEquity Inc. stock a dividend growth opportunityNew Guidance & Verified Momentum Watchlists - newser.com
What analysts say about HealthEquity Inc 2HE stockTrading Volume Trends & Superior Growth Trading - Early Times
Will Fresh Leadership in Sales and Marketing Shift HealthEquity's (HQY) Long-Term Growth Narrative? - Sahm
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - sharewise.com
Zacks Research Reduces Earnings Estimates for HealthEquity - MarketBeat
HealthEquity appoints two senior executives amid HSA expansion By Investing.com - Investing.com Nigeria
HealthEquity, Inc. Announces Executive Appointments, Effective September 29, 2025 - MarketScreener
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):